Anti-fibrotic effects of bone morphogenetic protein-7-modified bone marrow mesenchymal stem cells on silica-induced pulmonary fibrosis

Experimental and Molecular Pathology

Volumn 102, Issue 1, 2017, Pages 70-77

  Li, Xiaoli ^a   An, Guoliang ^a   Wang, Yan ^a   Liang, Di ^a   Zhu, Zhonghui ^a   Lian, Ximeng ^a   Niu, Piye ^a   Guo, Caixia ^a   Tian, Lin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cells; Bone morphogenetic protein 7; Pulmonary fibrosis; Silicosis

Indexed keywords

AQUAPORIN 5; FIBRONECTIN; HYDROXYPROLINE; OSTEOGENIC PROTEIN 1; SODIUM CHLORIDE; SURFACTANT PROTEIN C; TRANSFORMING GROWTH FACTOR BETA1; PEPTIDE; SFTPC PROTEIN, RAT; SILICON DIOXIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL PULMONARY FIBROSIS; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SILICA INDUCED PULMONARY FIBROSIS; STAINING; WISTAR RAT; ANIMAL; BONE DEVELOPMENT; BRONCHOALVEOLAR LAVAGE FLUID; CELL CULTURE; CHEMICALLY INDUCED; CHEMISTRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PROCEDURES; PULMONARY FIBROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; AQUAPORIN 5; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 7; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; FEMALE; FIBRONECTINS; GENE EXPRESSION; HYDROXYPROLINE; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROSCOPY, FLUORESCENCE; OSTEOGENESIS; PEPTIDES; PULMONARY FIBROSIS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SILICON DIOXIDE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85008604291     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2016.12.010     Document Type: Article

References (35)

1. Cruz, F.F., Rocco, P.R., Hypoxic preconditioning enhances mesenchymal stromal cell lung repair capacity. Stem Cell Res. Ther., 6, 2015, 130.
2. De Langhe, E., et al. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis. Respir. Res., 16, 2015, 38.
3. Dominici, M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006), 315–317.
4. Dong, L.H., et al. The anti-fibrotic effects of mesenchymal stem cells on irradiated lungs via stimulating endogenous secretion of HGF and PGE2. Sci. Rep., 5, 2015, 8713.
5. Englert, J.M., et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am. J. Pathol. 172 (2008), 583–591.
6. Fattman, C.L., et al. Increased sensitivity to asbestos-induced lung injury in mice lacking extracellular superoxide dismutase. Free Radic. Biol. Med. 40 (2006), 601–607.
7. Fiore, E.J., et al. Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice. Stem Cells Dev. 24 (2015), 791–801.
8. Galie, P.A., Stegemann, J.P., Injection of mesenchymal stromal cells into a mechanically stimulated in vitro model of cardiac fibrosis has paracrine effects on resident fibroblasts. Cytotherapy 16 (2014), 906–914.
9. Greenberg, M.I., et al. Silicosis: a review. Dis. Mon. 53 (2007), 394–416.
10. Keating, A., Mesenchymal stromal cells: new directions. Cell Stem Cell 10 (2012), 709–716.
11. Kotton, D.N., B. Y. M., Cardoso, W.V., Sanderson, E.A., Summer, R.S., Williams, M.C., Fine, A., Bone Marrow-Derived Cells as Progenitors of Lung Alveolar Epithelium. 2001.
12. Lan, Y.W., et al. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Res. Ther., 6, 2015, 97.
13. Leung, C.C., et al. Silicosis. Lancet 379 (2012), 2008–2018.
14. Li, W., et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25 (2007), 2118–2127.
15. Li, R.X., et al. Role of bone morphogenetic protein-7 in renal fibrosis. Front. Physiol., 6, 2015, 114.
16. Liang, D., et al. Increased expression of bone morphogenetic protein-7 and its related pathway provides an anti-fibrotic effect on silica induced fibrosis in vitro. Toxicol. Res 4 (2015), 1511–1522.
17. Liang, D., et al. BMP-7 attenuated silica-induced pulmonary fibrosis through modulation of the balance between TGF-beta/Smad and BMP-7/Smad signaling pathway. Chem. Biol. Interact. 243 (2016), 72–81.
18. Liu, N., et al. Alleviation of apoptosis of bone marrow-derived mesenchymal stem cells in the acute injured kidney by heme oxygenase-1 gene modification. Int. J. Biochem. Cell Biol. 69 (2015), 85–94.
19. Lv, S., et al. Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-beta signalling via secretion of bone morphogenetic protein 7. Diab. Vasc. Dis. Res. 11 (2014), 251–261.
20. Manson, S.R., et al. HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-beta mediated renal fibrosis in obstructive uropathy. J. Urol. 191 (2014), 242–252.
21. Ni, S., et al. Bone marrow mesenchymal stem cells protect against bleomycin-induced pulmonary fibrosis in rat by activating Nrf2 signaling. Int. J. Clin. Exp. Pathol. 8 (2015), 7752–7761.
22. Ortiz, L.A., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 8407–8411.
23. Peng, Y., et al. Freeze-dried rat bone marrow mesenchymal stem cell paracrine factors: a simplified novel material for skin wound therapy. Tissue Eng. Part A 21 (2015), 1036–1046.
24. Steenland, K., Ward, E., Silica: a lung carcinogen. CA Cancer J. Clin. 64 (2014), 63–69.
25. Ueno, T., et al. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta1 signaling. Kidney Int. 84 (2013), 297–307.
26. Urbina, P., Singla, D.K., BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 307 (2014), H762–H772.
27. Wang, N., et al. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6. PLoS One, 7, 2012, e43768.
28. Wang, L.P., et al. BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor. Int. J. Clin. Exp. Pathol. 7 (2014), 3537–3547.
29. Wang, Y., et al. Effect of bone morphogenic protein-7 on the expression of epithelial-mesenchymal transition markers in silicosis model. Exp. Mol. Pathol. 98 (2015), 393–402.
30. Xu, J., et al. Cyclophosphamide combined with bone marrow mesenchymal stromal cells protects against bleomycin-induced lung fibrosis in mice. Ann. Clin. Lab. Sci. 45 (2015), 292–300.
31. Xue, J., et al. Gene-modified mesenchymal stem cells protect against radiation-induced lung injury. Mol. Ther. 21 (2013), 456–465.
32. Yang, G., et al. Bone morphogenetic protein-7 inhibits silica-induced pulmonary fibrosis in rats. Toxicol. Lett. 220 (2013), 103–108.
33. Yang, G., et al. Bone morphogenetic protein 7 attenuates epithelial-mesenchymal transition induced by silica. Hum. Exp. Toxicol. 35 (2016), 69–77.
34. Zhang, W., et al. VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. Eur. Cell. Mater. 27 (2014), 1–11 (discussion 11-2).
35. Zhu, Z., et al. Suppression of thioredoxin system contributes to silica-induced oxidative stress and pulmonary fibrogenesis in rats. Toxicol. Lett. 222 (2013), 289–294.